An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Several professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Platform Response and Material Elimination
According to TikTok, the service has removed violative content and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at home.
Within moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.
Product Information and Costs
Inside these groups, messages show dark colored packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they can’t verify. Although the research behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to potentially serious health risks”.
